BSE filing, BSE: 543497. Summary written from the filing by ALFA Finder's alert engine.
Bhatia Colour Chem Ltd: key numbers
- Share price
- ₹19.83
- Market cap
- ₹28.04 Cr
- Revenue (annual)
- ₹154.6 Cr
- Net profit (annual)
- ₹4.18 Cr
- P/E (TTM)
- 6.7×Sector 34.1×
- Promoter holding
- 40.50%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bhatia Colour Chem Ltd
All →Bhatia Colour Chem Other Announcement
Bhatia Colour Chem Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulatory requirements.
Bhatia Colour Chem Annual General Meeting
Bhatia Colour Chem Limited held its 5th Annual General Meeting on August 25, 2026. Shareholders considered and adopted financial statements and approved various reappointments and transactions.
Bhatia Colour Chem Annual Report
Bhatia Colour Chem Ltd has filed its Annual Report for the financial year 2025-26. The report includes the Board's report and auditor's reports.
Bhatia Colour Chem Annual General Meeting
Bhatia Colour Chem Ltd issued a notice for its 5th Annual General Meeting scheduled for August 25, 2026. Agenda includes financial statements and director re-appointments.
Bhatia Colour Chem Management Change
Bhatia Colour Chem Limited's board approved the reappointment of Bharat Brijlal Bhatia as Managing Director. Reappointments for Whole Time Directors Rameshchand Bhatia and Ravi Bhatia were also approved.
Bhatia Colour Chem Capital Structure Change
Bhatia Colour Chem Ltd converted 1.98 lakh warrants into equity shares at Rs.134 each. This capital event raises Rs.2.62 Crore, increasing paid-up capital.
- Value
- ₹2.62 Cr
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.